Search Results 431-440 of 11981 for ���������������������������:za33���24������ ������������������������ ������

  1. A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - Mayo Clinic

    Jacksonville, Florida: 24-007776; Scottsdale/Phoenix, Arizona: 24-007776. NCT ID: NCT06419374. Sponsor Protocol Number: BIO89-100-132. About this study. The ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Zafirlukast (oral route) - Mayo Clinic

    Zafirlukast is used to help control the symptoms of asthma and improve lung function. However, this medicine should not be used to relieve an asthma attack that ...

  6. Deb Balzer | Mayo Clinic News Network - Page 58 of 72

    Nipunie[...] By Deb Balzer • July 24, 2017. Infectious Diseases A-Z: Salmonella safety. Salmonella infection is one of the most common forms of foodborne ...

  7. Serum Derived From Patient Donors With Paraneoplastic Pemphigus (PNP) to Be Used as a Positive Control for PNP Test - Mayo Clinic

    Rochester, Minnesota: 24-011306. About this study. The purpose of this study is to obtain serum from patients with certain rare immunobullous diseases (e.g. ...

  8. Trial of 225Ac-DOTATATE (RYZ101) Alone and with Pembrolizumab in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs (TRACY-1) - Mayo Clinic

    Jacksonville, Florida: 24-010409; Scottsdale/Phoenix, Arizona: 24-010409. NCT ID: NCT06590857. Sponsor Protocol Number: RYZ101-201. About this study. The ...

  9. Clinical trials - Oncology (Medical)

    24, 2024. Share on: FacebookTwitter · Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida, and Mayo Clinic in Phoenix/Scottsdale, Arizona ...

  10. Zagociguat in Participants With Melas (Prizm) - Mayo Clinic

    Rochester, Minnesota: 24-004117. NCT ID: NCT06402123. Sponsor Protocol Number: TIS6463-203. About this study. The purpose of this study is to evaluate the ...